Annual Reports

FY20 Annual Report

The 2020 financial year was challenging and one for which we evolved rapidly to meet head on. Managing the impact of COVID-19 is one of the fundamental challenges that all companies have faced this year. In light of COVID-19 and the evolving advice to the general public, Dimerix implemented a number of contingency plans in the event trial participants were required to self-isolate, became ill or visits to medical institutions were restricted. Thanks to the foresight of the operational team running the DMX-200 studies who started implementation of these risk-mitigation strategies in February 2020, we were delighted to meet all of our key milestones on schedule.

Download Opens in new window

Join the Dimerix mailing list to receive the latest company news.

Join now